Compare BAK & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BAK | ASTH |
|---|---|---|
| Founded | 1972 | 1994 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Professional Services |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | N/A | N/A |
| Metric | BAK | ASTH |
|---|---|---|
| Price | $3.10 | $26.95 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | $4.40 | ★ $41.33 |
| AVG Volume (30 Days) | ★ 1.1M | 508.2K |
| Earning Date | 02-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | ★ $13,841,708,237.00 | $2,896,452,000.00 |
| Revenue This Year | N/A | $58.46 |
| Revenue Next Year | $7.81 | $25.59 |
| P/E Ratio | ★ N/A | $137.95 |
| Revenue Growth | N/A | ★ 68.17 |
| 52 Week Low | $2.32 | $20.12 |
| 52 Week High | $5.10 | $39.97 |
| Indicator | BAK | ASTH |
|---|---|---|
| Relative Strength Index (RSI) | 54.60 | 55.21 |
| Support Level | $3.05 | $25.52 |
| Resistance Level | $3.37 | $27.80 |
| Average True Range (ATR) | 0.13 | 1.34 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 51.38 | 52.06 |
Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities. The company's geographical segments include Brazil; the United States and Europe and Mexico. It derives a majority of its revenue from Brazil. It produces olefins, such as ethylene, polymer and chemical-grade propylene, butadiene, and butene-1; fuels, such as automotive gasoline, liquefied petroleum gas, or LPG, ethyl tertiary-butyl ether, or ETBE, and methyl tertiary-butyl ether, or MTBE; intermediates, such as cumene and others.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.